# Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

> **NCT00758498** · PHASE3 · COMPLETED · sponsor: **Cephalon** · enrollment: 427 (actual)

## Conditions studied

- Excessive Sleepiness

## Interventions

- **DRUG:** armodafinil
- **DRUG:** armodafinil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00758498
- **Lead sponsor:** Cephalon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 427 (ACTUAL)
- **Last updated:** 2013-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00758498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00758498, "Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00758498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*